Effects of smoking cessation on insulin and cardiovascular risk factors – a controlled study of 4 months' duration
The DOI matches its Crossref record.
Abstract
Objectives. To investigate the effects on serum lipids, plasma fibrinogen, plasma insulin, plasma C‐peptide and blood glucose, of smoking cessation after 4 months. To develop a group‐based smoking intervention programme in primary health care. Setting. Twenty health centres in primary health care in southern Sweden. Subjects. Four hundred habitual smokers (>10 cigarettes per day‐1, >10 years), recruited by advertisement in local papers. Intervention. The smokers were randomized, after stratification for age and sex, to one intervention group (n=200) and one control group (n=200). The intervention group was offered supportive group sessions and free nicotine supplementation (patches, chewing gum). Main outcome measures. All participants were investigated at the start and after 4 months (medical history, physical examination, laboratory evaluation). Blood samples were drawn for determination of glucose, insulin and C‐peptide, both in the fasting state and during an oral glucose tolerance test (OGTT), and for measurement of lipoproteins, fibrinogen, nicotine and cotinine. Results. In the intervention group 98 of the subjects (48%) had quit smoking after 4 months. They were compared with the 156 subjects in the control group (91%) who were still daily smokers during the whole period. There were no significant differences in any variable between the two (total) experimental groups at baseline. Plasma nicotine and cotinine decreased (P<0.001) in the intervention group following smoking cessation, and weight increased by 2.7 kg. In the intervention group HDL‐cholesterol increased by 11% (P<0.001), whereas HbA 1c increased by 2% (P<0.05) only in the control group. No changes occurred in levels of glucose, insulin, C‐peptide and fibrinogen. Conclusion. The smoking cessation programme had a success rate of almost 50% over 4 months. Smoking cessation was associated with a marked increase in HDL‐cholesterol levels but did not affect glucose tolerance. A concomitant weight increase may have blunted any independent beneficial effect of smoking cessation on glucose metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Combined pharmacotherapy and behavioural interventions for smoking cessation
Stead, L. F., Koilpillai, P., Fanshawe, T. R., & Lancaster, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008286.pub3 · Cited by 829
Cardiovascular Events Associated With Smoking Cessation Pharmacotherapies: A Network Meta-Analysis
Mills, E. J., Thorlund, K., Eapen, S., Wu, P., & Prochaska, J. J. (2014) · Circulation · doi:10.1161/circulationaha.113.003961 · Cited by 408
The emerging role of HDL in glucose metabolism
Drew, B. G., Rye, K.-A., Duffy, S. J., Barter, P., & Kingwell, B. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.235 · Cited by 307
Coronary heart disease in individuals with spinal cord injury: assessment of risk factors
Bauman, W. A., & Spungen, A. M. (2008) · Spinal Cord · doi:10.1038/sj.sc.3102161 · Cited by 276
Maeda, K., Noguchi, Y., & Fukui, T. (2003) · Preventive Medicine · doi:10.1016/s0091-7435(03)00110-5 · Cited by 242
Metadata
- Authors
- NILSSON, P., LUNDGREN, H., SÖDERSTRÖM, M., FAGERSTRÖM, K., & NILSSON‐EHLE, P.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 1996-10
- Volume
- 240
- Issue
- 4
- Pages
- 189-194
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W1970668311
- Cited by
- 49
- References
- 0
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of smoking cessation on insulin and cardiovascular risk factors – a controlled study of 4 months' duration. https://app.cochat.ai/papers/10.1046/j.1365-2796.1996.16844000.x
- The paper
- NILSSON, P., LUNDGREN, H., SÖDERSTRÖM, M., FAGERSTRÖM, K., & NILSSON‐EHLE, P. (1996). Effects of smoking cessation on insulin and cardiovascular risk factors – a controlled study of 4 months' duration. Journal of Internal Medicine. https://doi.org/10.1046/j.1365-2796.1996.16844000.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.